vs

Side-by-side financial comparison of AEMETIS, INC (AMTX) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

AEMETIS, INC is the larger business by last-quarter revenue ($43.3M vs $38.9M, roughly 1.1× CODEXIS, INC.). On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -7.9%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $-10.8M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -22.8%).

Aemetis, Inc. is a renewable fuels and sustainable biochemicals producer operating across North America and India. Its core products include low-carbon ethanol, renewable natural gas and biodiesel, serving transportation, industrial and agricultural sectors with decarbonization solutions for commercial clients.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

AMTX vs CDXS — Head-to-Head

Bigger by revenue
AMTX
AMTX
1.1× larger
AMTX
$43.3M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+89.2% gap
CDXS
81.3%
-7.9%
AMTX
More free cash flow
CDXS
CDXS
$30.4M more FCF
CDXS
$19.6M
$-10.8M
AMTX
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-22.8%
AMTX

Income Statement — Q4 2025 vs Q4 2025

Metric
AMTX
AMTX
CDXS
CDXS
Revenue
$43.3M
$38.9M
Net Profit
$9.6M
Gross Margin
17.8%
94.8%
Operating Margin
-5.7%
27.1%
Net Margin
24.7%
Revenue YoY
-7.9%
81.3%
Net Profit YoY
192.5%
EPS (diluted)
$-0.03
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMTX
AMTX
CDXS
CDXS
Q4 25
$43.3M
$38.9M
Q3 25
$59.2M
$8.6M
Q2 25
$52.2M
$15.3M
Q1 25
$42.9M
$7.5M
Q4 24
$47.0M
$21.5M
Q3 24
$81.4M
$12.8M
Q2 24
$66.6M
$8.0M
Q1 24
$72.6M
$17.1M
Net Profit
AMTX
AMTX
CDXS
CDXS
Q4 25
$9.6M
Q3 25
$-23.7M
$-19.6M
Q2 25
$-23.4M
$-13.3M
Q1 25
$-24.5M
$-20.7M
Q4 24
$-10.4M
Q3 24
$-17.9M
$-20.6M
Q2 24
$-29.2M
$-22.8M
Q1 24
$-24.2M
$-11.5M
Gross Margin
AMTX
AMTX
CDXS
CDXS
Q4 25
17.8%
94.8%
Q3 25
-0.1%
71.3%
Q2 25
-6.4%
86.3%
Q1 25
-11.8%
63.8%
Q4 24
-4.3%
83.0%
Q3 24
4.8%
66.4%
Q2 24
-2.7%
56.6%
Q1 24
-0.8%
71.6%
Operating Margin
AMTX
AMTX
CDXS
CDXS
Q4 25
-5.7%
27.1%
Q3 25
-14.4%
-220.3%
Q2 25
-20.4%
-83.9%
Q1 25
-36.3%
-271.6%
Q4 24
-28.7%
-34.2%
Q3 24
-4.8%
-129.0%
Q2 24
-20.4%
-284.9%
Q1 24
-13.0%
-69.6%
Net Margin
AMTX
AMTX
CDXS
CDXS
Q4 25
24.7%
Q3 25
-40.1%
-228.1%
Q2 25
-44.8%
-86.6%
Q1 25
-57.2%
-274.3%
Q4 24
-48.4%
Q3 24
-22.0%
-160.8%
Q2 24
-43.8%
-285.2%
Q1 24
-33.4%
-67.4%
EPS (diluted)
AMTX
AMTX
CDXS
CDXS
Q4 25
$-0.03
$0.13
Q3 25
$-0.37
$-0.22
Q2 25
$-0.41
$-0.16
Q1 25
$-0.47
$-0.25
Q4 24
$-0.29
$-0.12
Q3 24
$-0.38
$-0.29
Q2 24
$-0.66
$-0.32
Q1 24
$-0.58
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMTX
AMTX
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$4.9M
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$-306.8M
$50.5M
Total Assets
$259.8M
$147.8M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMTX
AMTX
CDXS
CDXS
Q4 25
$4.9M
$78.2M
Q3 25
$5.6M
$58.7M
Q2 25
$1.6M
$66.3M
Q1 25
$499.0K
$59.8M
Q4 24
$898.0K
$73.5M
Q3 24
$296.0K
$90.3M
Q2 24
$234.0K
$73.2M
Q1 24
$1.6M
$85.5M
Total Debt
AMTX
AMTX
CDXS
CDXS
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$338.1M
$28.9M
Q3 24
$322.2M
$28.6M
Q2 24
$309.0M
$28.4M
Q1 24
$307.2M
$28.1M
Stockholders' Equity
AMTX
AMTX
CDXS
CDXS
Q4 25
$-306.8M
$50.5M
Q3 25
$-304.9M
$38.5M
Q2 25
$-289.3M
$55.6M
Q1 25
$-280.7M
$49.6M
Q4 24
$-263.9M
$66.9M
Q3 24
$-258.9M
$73.4M
Q2 24
$-249.0M
$61.4M
Q1 24
$-232.1M
$79.3M
Total Assets
AMTX
AMTX
CDXS
CDXS
Q4 25
$259.8M
$147.8M
Q3 25
$241.1M
$124.0M
Q2 25
$240.0M
$138.2M
Q1 25
$242.5M
$128.9M
Q4 24
$259.3M
$149.0M
Q3 24
$259.3M
$148.2M
Q2 24
$259.3M
$132.0M
Q1 24
$259.3M
$149.6M
Debt / Equity
AMTX
AMTX
CDXS
CDXS
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMTX
AMTX
CDXS
CDXS
Operating Cash FlowLast quarter
$5.8M
$20.1M
Free Cash FlowOCF − Capex
$-10.8M
$19.6M
FCF MarginFCF / Revenue
-24.9%
50.3%
Capex IntensityCapex / Revenue
38.2%
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-22.7M
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMTX
AMTX
CDXS
CDXS
Q4 25
$5.8M
$20.1M
Q3 25
$3.1M
$-7.7M
Q2 25
$-5.7M
$-18.0M
Q1 25
$160.0K
$-13.8M
Q4 24
$-12.6M
$-16.5M
Q3 24
$-5.0M
$-13.0M
Q2 24
$-5.1M
$-12.2M
Q1 24
$-10.3M
$-7.8M
Free Cash Flow
AMTX
AMTX
CDXS
CDXS
Q4 25
$-10.8M
$19.6M
Q3 25
$-1.0M
$-7.9M
Q2 25
$-9.3M
$-20.5M
Q1 25
$-1.7M
$-15.1M
Q4 24
$-19.4M
$-18.2M
Q3 24
$-9.5M
$-14.0M
Q2 24
$-10.5M
$-12.6M
Q1 24
$-13.9M
$-8.9M
FCF Margin
AMTX
AMTX
CDXS
CDXS
Q4 25
-24.9%
50.3%
Q3 25
-1.7%
-91.7%
Q2 25
-17.7%
-133.6%
Q1 25
-3.9%
-199.6%
Q4 24
-41.2%
-85.0%
Q3 24
-11.6%
-109.0%
Q2 24
-15.8%
-157.5%
Q1 24
-19.1%
-52.2%
Capex Intensity
AMTX
AMTX
CDXS
CDXS
Q4 25
38.2%
1.3%
Q3 25
6.9%
2.1%
Q2 25
6.7%
16.4%
Q1 25
4.3%
16.7%
Q4 24
14.4%
8.3%
Q3 24
5.5%
7.8%
Q2 24
8.1%
5.0%
Q1 24
4.9%
6.6%
Cash Conversion
AMTX
AMTX
CDXS
CDXS
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMTX
AMTX

Ethanol Sales$28.8M66%
Wet Distillers Grains$6.8M16%
California Dairy Renewable Natural Gas$5.2M12%
Other$1.8M4%

CDXS
CDXS

Segment breakdown not available.

Related Comparisons